SCHEMBL3758445

SCHEMBL3758445

CCCc1ccc(OP(=O)(Cl)Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
CYP2C19 P33261 1/20 0.44
ALDH1A1 P00352 3/20 0.42
RAB9A P51151 2/20 0.42
PLK1 P53350 1/20 0.42
POLB P06746 2/20 0.41
CTDSP1 Q9GZU7 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
NPC1 O15118 2/20 0.40
MAPT P10636 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
CA2 P00918 1/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11506602 0.86 ENPP2 (0.54) THRBSMN1; SMN2ALDH1A1KDM4EPPARA
SCHEMBL1592157 0.84 CYP3A4 (0.54) THRBSMN1; SMN2CYP2C19ALDH1A1RAB9A
SCHEMBL3755582 0.84 SMN1; SMN2 (0.61) SMN1; SMN2CYP2C19ALDH1A1RAB9APLK1
SCHEMBL3758449 0.81 THRB (0.44) THRBSMN1; SMN2CYP2C19ALDH1A1RAB9A
SCHEMBL1100625 0.81 BLM (0.58) THRBSMN1; SMN2CYP2C19ALDH1A1PLK1
SCHEMBL29045013 0.79 BLM (0.56) THRBSMN1; SMN2CYP2C19ALDH1A1RAB9A
SCHEMBL6286500 0.79 THRB (0.45) THRBSMN1; SMN2CYP2C19ALDH1A1RAB9A
SCHEMBL10015246 0.78 MEN1 (0.48) SMN1; SMN2CYP2C19KDM4ECA2KMT2A
SCHEMBL381597 0.78 L3MBTL1 (0.47) THRBSMN1; SMN2CYP2C19KMT2A
SCHEMBL1960392 0.78 L3MBTL1 (0.47) THRBSMN1; SMN2CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298506-A1 METHOD FOR PRODUCING AN AMINO GROUP-CONTAINING PHOSPHATE COMPOUND, AND A FLAME-RETARDANT RESIN AND FLAME-RETARDANT RESIN COMPOSITION SHOWA HIGHPOLYMER CO., LTD. (JP) 2010-11-25 US disclosed
EP-2036911-A1 PROCESS FOR PRODUCTION OF AMINATED PHOSPHORIC ACID ESTER COMPOUND, FLAME-RETARDANT RESIN, AND FLAME-RETARDANT RESIN COMPOSITION SHOWA HIGHPOLYMER CO., LTD. (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298506-A1 METHOD FOR PRODUCING AN AMINO GROUP-CONTAINING PHOSPHATE COMPOUND, AND A FLAME-RETARDANT RESIN AND FLAME-RETARDANT RESIN COMPOSITION ATIC, GART, RPP30 THRB 3475/4885SMN1; SMN2 4067/4885CYP2C19 2840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.